Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.

Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation

Abstract

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog developed for type 2 diabetes. Long-term liraglutide exposure in rodents was associated with thyroid C-cell hyperplasia and tumors. Here, we report data supporting a GLP-1 receptor-mediated mechanism for these changes in rodents. The GLP-1 receptor was localized to rodent C-cells. GLP-1 receptor agonists stimulated calcitonin release, up-regulation of calcitonin gene expression, and subsequently C-cell hyperplasia in rats and, to a lesser extent, in mice. In contrast, humans and/or cynomolgus monkeys had low GLP-1 receptor expression in thyroid C-cells, and GLP-1 receptor agonists did not activate adenylate cyclase or generate calcitonin release in primates. Moreover, 20 months of liraglutide treatment (at >60 times human exposure levels) did not lead to C-cell hyperplasia in monkeys. Mean calcitonin levels in patients exposed to liraglutide for 2 yr remained at the lower end of the normal range, and there was no difference in the proportion of patients with calcitonin levels increasing above the clinically relevant cutoff level of 20 pg/ml. Our findings delineate important species-specific differences in GLP-1 receptor expression and action in the thyroid. Nevertheless, the long-term consequences of sustained GLP-1 receptor activation in the human thyroid remain unknown and merit further investigation.

Overview

Integrity signals

Registry

Crossref · 10.1210/en.2009-1272

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 48 references

Research works printed but not linked: 4

  1. Leong, 1981, A new cell line for studies on human thyroid medullary carcinoma., Rev Hosp Clin Fac Med Sao Paulo, 58, 310
  2. Hiles, 2004, Exenatide does not cause pancreatic islet cell proliferative lesions in rats and mice following 2-year exposure., Diabetologia, 47, A208
  3. Food and Drug Administration 2005 Byetta (exenatide), pharmacology review 2005.
  4. Food and Drug Administration 2002 Forteo (teriparatide), medical review 2002: Part 3.

Cited by

See all 672

Metadata

Authors
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., Jacobsen, S. D., Moses, A. C., Mølck, A.-M., Nielsen, H. S., Nowak, J., Solberg, H., Thi, T. D. L., & Zdravkovic, M.
Affiliations
  • Novo Nordisk A/S (L.B.K., L.W.M., S.A., K.A., A.S.d.B., C.G., F.L.E., A.C.H., H.J., S.D.J., A.C.M., A.M.M., H.S.N., J.N., H.S., T.D.L.T., M.Z.), DK-2760 Maaloev, Denmark
  • Novo Nordisk (Denmark) (DK)
  • Mount Sinai Hospital (CA)
Venue
Endocrinology
Published
2010-03-04
Volume
151
Issue
4
Pages
1473-1486
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2004409542
Cited by
672
References
48
Citations by year
2026: 55 · 2025: 83 · 2024: 58 · 2023: 29 · 2022: 26 · 2021: 18 · 2020: 17 · 2019: 28 · 2018: 26 · 2017: 38 · 2016: 25 · 2015: 39 · 2014: 42 · 2013: 56 · 2012: 48
FWCI
45.11
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Amylin Pharmaceuticals
  • Novo Nordisk
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
GLP-1 receptor agonists, liraglutide, thyroid C cells, C-cell hyperplasia, species differences, drug safety, type 2 diabetes, adenylate cyclase, thyroid cancer risk
MeSH terms
Glucagon-Like Peptide-1 Receptor, Liraglutide, Cyclic AMP, Animals, Calcitonin, Cell Line, Cells, Cultured, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Humans, Immunohistochemistry, Macaca fascicularis, Obesity, Radioimmunoassay, RNA, Messenger, Species Specificity, Thyroid Gland, Blotting, Western, Gene Expression, Rats, Sprague-Dawley, In Situ Hybridization, Receptors, Glucagon, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Cell Proliferation, Mice, Rats, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation. https://app.cochat.ai/papers/10.1210/en.2009-1272
The paper
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., Jacobsen, S. D., Moses, A. C., Mølck, A.-M., Nielsen, H. S., Nowak, J., Solberg, H., Thi, T. D. L., & Zdravkovic, M. (2010). Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation. Endocrinology. https://doi.org/10.1210/en.2009-1272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.